GHK-Cu and AHK-Cu: What Changes When One Amino Acid Changes?

GHK-Cu and AHK-Cu differ by one amino acid, yet their names should not be treated as interchangeable. GHK contains glycine, histidine and lysine; AHK contains alanine, histidine and lysine. The Cu designation refers to a copper complex. That small structural difference is a useful starting point for a comparison, but it cannot by itself predict which compound will produce a particular biological outcome.

Their research histories also differ. GHK-Cu has been investigated in connective-tissue models and copper-binding chemistry. AHK-Cu has a notable experimental literature involving hair follicles and dermal papilla cells. Understanding the methods behind those observations is more informative than reducing the comparison to “skin versus hair.”

The copper complex is part of the identity

A copper peptide is more than a peptide name followed by a mineral. Researchers study how the metal coordinates with the peptide and how surrounding conditions influence the resulting complex. Thermodynamic experiments on GHK demonstrated strong copper binding under defined conditions; they also showed why measurements must account for competing ligands and the experimental buffer.

Those details matter when comparing papers. A result obtained with one chemical environment does not automatically describe every formulation carrying the same headline ingredient. The study also examined DAHK, a four-amino-acid sequence: it should not be mistaken for the three-amino-acid AHK discussed here. Trapaidze and colleagues, 2012.

What GHK-Cu research actually measured

An early GHK-Cu study examined collagen synthesis in fibroblast cultures. Fibroblasts are cells involved in producing connective-tissue components. The researchers reported increased collagen synthesis under their experimental conditions, without a corresponding increase in cell number. That distinction helped separate the measured biochemical response from simple proliferation.

The finding is relevant to the history of skin and tissue research, but a culture dish does not reproduce the entire skin barrier, immune environment or healing process. It cannot establish the performance of an arbitrary finished skincare product or a research vial in humans. Maquart and colleagues, 1988.

A later experiment used wound chambers in rats and measured the accumulation of proteins and extracellular-matrix components. It provided an in-vivo extension of the laboratory question, with increases in several measured tissue constituents. The appropriate conclusion remains specific to that animal model. It is not a direct demonstration of reduced wrinkles or improved surgical healing in people. Maquart and colleagues, 1993.

What makes AHK-Cu interesting in hair research

The frequently cited AHK-Cu study investigated isolated human hair follicles and cultured dermal papilla cells. Dermal papilla cells participate in the signaling environment of the follicle. Researchers observed follicle elongation in organ culture and increased proliferation of the cultured cells. They also examined markers associated with cell survival; not every result reached statistical significance.

These are useful mechanistic observations. However, isolated human tissue is still an experimental model, not a clinical trial of hair restoration. It does not establish visible regrowth on a scalp, long-term durability or effectiveness across different causes of hair loss. The use of human-derived cells should not obscure that distinction. Pyo and colleagues, 2007.

Why formulation prevents a simple ranking

Even before considering biological effects, a compound must be evaluated in the formulation and model actually used. A GHK-Cu transport study used a laboratory membrane system to investigate how copper-peptide species moved across a model of the outer skin barrier. The results depended on the experimental chemical environment.

That finding illustrates a broader reading principle: molecular activity, movement through a model membrane and clinical performance are separate questions. Evidence at one level cannot answer all three. Neither a positive cell experiment nor the presence of a copper peptide on an ingredient list is enough to establish the outcome of a finished product. Model-membrane transport study.

Comparing the evidence without oversimplifying it

Calling GHK-Cu a skin peptide and AHK-Cu a hair peptide can help orient a reader, but it is not a strict biological boundary or a validated clinical ranking. The evidence reviewed here does not establish that one should replace the other, or that combining them produces superior results.

For a research comparison, keep the question narrow and the materials identifiable. Record the sequence and copper-complex identity, use comparable analytical documentation, and distinguish a cellular endpoint from a visible tissue outcome. These choices make results easier to interpret than relying on the similarity of product names.

Evidence limitations

The cited studies use different compounds, experimental systems and endpoints. Most are mechanistic or preclinical; the AHK-Cu follicle work is ex vivo. They do not provide a direct clinical head-to-head comparison. This article therefore makes no claim that either compound is a proven treatment for hair loss or a general anti-aging intervention. Research materials and finished, evaluated formulations should remain distinct in any discussion of performance or safety.

Reviewed September 12, 2026. This article is educational and does not provide instructions for human use.

Primary references

• Trapaidze et al. — thermodynamics of copper binding to GHK and DAHK, 2012.
• Maquart et al. — fibroblast collagen-synthesis study, 1988.
• Maquart et al. — rat experimental wound study, 1993.
• Pyo et al. — AHK-Cu, hair follicles and dermal papilla cells, 2007.
• GHK-Cu transport through a model skin membrane.